Patent Leaderboard
USPTO Patent Rankings Data through Dec 31, 2025
Home › Isoquiniline and napthalene-substituted compounds as mGluR4 allosteric potentiators, compositions, and methods of treating neurological dysfunction

Isoquiniline and napthalene-substituted compounds as mGluR4 allosteric potentiators, compositions, and methods of treating neurological dysfunction

US Patent 10227343 · Granted Mar 12, 2019

Assignee

Inventors

View full patent text on Google Patents →

More Patents by These Inventors

Positive modulators of the muscarinic acetylcholine receptor M42025
Positive modulators of the muscarinic acetylcholine receptor M42025
Positive modulators of the muscarinic acetylcholine receptor M42025
Positive modulators of the muscarinic acetylcholine receptor M42025
Substituted pyrimido[1,2-b]pyridazines as positive allosteric modulators of the 2025
Substituted pyrimido[1,2-b]pyridazines as positive allosteric modulators of the 2025
Substituted pyrimido[1,2-b]pyridazines as positive allosteric modulators of the 2025
Antagonists of the muscarinic acetylcholine receptor M42025
Antagonists of the muscarinic acetylcholine receptor M42025
Janus kinase (JAK) family inhibitor, preparation of same, and applications there2025
Indazole compounds as mGluR4 allosteric potentiators, compositions, and methods 2025
Indazole compounds as mGluR4 allosteric potentiators, compositions, and methods 2025